Potential Immunotherapeutics for Immunosuppression in Sepsis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shin, Jinwook | - |
dc.contributor.author | Jin, Mirim | - |
dc.date.available | 2020-02-27T16:43:43Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2017-11 | - |
dc.identifier.issn | 1976-9148 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5548 | - |
dc.description.abstract | Sepsis is a syndrome characterized by systemic inflammatory responses to a severe infection. Acute hyper-inflammatory reactions in the acute phase of sepsis have been considered as a primary reason for organ dysfunction and mortality, and advances in emergency intervention and improved intensive care management have reduced mortalities in the early phase. However it has been recognized that increased deaths in the late phase still maintain sepsis mortality high worldwide. Patients recovered from early severe illness are unable to control immune system with sepsis-induced immunosuppression such as immunological tolerance, exhaustion and apoptosis, which make them vulnerable to nosocomial and opportunistic infections ultimately leading to threat to life. Based on strategies to reverse immunosuppression, recent developments in sepsis therapy are focused on molecules having immune enhancing activities. These efforts are focused on defining and revising the immunocompromised status associated with long-term mortality. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC APPLIED PHARMACOLOGY | - |
dc.relation.isPartOf | BIOMOLECULES & THERAPEUTICS | - |
dc.subject | TUMOR-NECROSIS-FACTOR | - |
dc.subject | INTENSIVE-CARE PATIENTS | - |
dc.subject | HLA-DR EXPRESSION | - |
dc.subject | DENDRITIC CELLS | - |
dc.subject | T-CELLS | - |
dc.subject | IMMUNE DYSFUNCTION | - |
dc.subject | SEPTIC SHOCK | - |
dc.subject | DOUBLE-BLIND | - |
dc.subject | NEUTROPHIL RECRUITMENT | - |
dc.subject | INFLAMMATORY RESPONSE | - |
dc.title | Potential Immunotherapeutics for Immunosuppression in Sepsis | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000415274600002 | - |
dc.identifier.doi | 10.4062/biomolther.2017.193 | - |
dc.identifier.bibliographicCitation | BIOMOLECULES & THERAPEUTICS, v.25, no.6, pp.569 - 577 | - |
dc.identifier.kciid | ART002280022 | - |
dc.identifier.scopusid | 2-s2.0-85033602087 | - |
dc.citation.endPage | 577 | - |
dc.citation.startPage | 569 | - |
dc.citation.title | BIOMOLECULES & THERAPEUTICS | - |
dc.citation.volume | 25 | - |
dc.citation.number | 6 | - |
dc.contributor.affiliatedAuthor | Jin, Mirim | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Sepsis | - |
dc.subject.keywordAuthor | Immunosuppression | - |
dc.subject.keywordAuthor | Immune modulators | - |
dc.subject.keywordAuthor | Immunotherapy | - |
dc.subject.keywordAuthor | Precision medicine | - |
dc.subject.keywordAuthor | Theranostics | - |
dc.subject.keywordPlus | TUMOR-NECROSIS-FACTOR | - |
dc.subject.keywordPlus | INTENSIVE-CARE PATIENTS | - |
dc.subject.keywordPlus | HLA-DR EXPRESSION | - |
dc.subject.keywordPlus | DENDRITIC CELLS | - |
dc.subject.keywordPlus | T-CELLS | - |
dc.subject.keywordPlus | IMMUNE DYSFUNCTION | - |
dc.subject.keywordPlus | SEPTIC SHOCK | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | NEUTROPHIL RECRUITMENT | - |
dc.subject.keywordPlus | INFLAMMATORY RESPONSE | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.